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Recent evidence has indicated that the 
spleen may be partly responsible for 
synthesis or storage of antihemophilic 
factor (factor VIII) in dogs (8) and in 
man (2). Transplantation of the spleen 
into dogs with congenital deficiency of fac-
tor VIII has been shown to result in in-
creased circulating levels of this clott.ing 
factor for prolonged periods (3). Spleen 
transplantation in man has been done 
without significant morbidity because of 
the procedure itself or graft-versus-host 
re~ction (1,5). Therefore, it seemed rea-
sonable to attempt allogeneic grafting of a 
spleen into a patient with severe factor 
VIII deficiency. 
CASE REPORT 
Q. 1\., a 16-year-old boy with hemophilia 
A (factor VIII, antihemophilic factor de-
ficiency), had been followed at the Uni-
versity of Colorado Medical Center from 
the age of 17 months. The diagnosis of 
severe hemophilia A had been confirmed 
many times. His factor VIII level was 0%, 
and bleeding times were normal. No anti-
body against factor VIII had ever been 
demonstrated. The patient's mother was 
shown to be a hemophiliac carrier with re-
peated factor VIII assays that ranged from 
26%-38% of normal. 
During the 14-year period that the pa-
tient was followed at this institution he 
required 41 hospital admissions for treat-
ment of hemarthroses involving almost all 
of the major joints, recurrent hemorrhages 
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into major muscle groups, bleeding from 
open lacerations, and retroperitoneal 
hemorrhages. 
On January 31, 1968, the patient was 
admitted to Colorado General Hospital for 
:111 elective splenic homotransplantation 
with the father as the donor. The only 
donor-recipient mismatch in the HLA (7) 
antigen system was in the Terasaki Group 
3. 
Two days prior to surgery the patient 
was given a "test" infusion of 1911 units of 
glycine-precipitated AHF (Hyland), and 
serial factor VIII assays were done. All 
factor VIII assays were done in duplicate 
by the method of Pool (4). The initial level 
of 27% factor VIII fell to 2% in 30 hr. 
During the same period administration of 
heterologous antilymphocyte globulin 
(ALG) and azathioprine (Imuran) was 
hegun (6). 
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Based on the results of the previously 
determined decay rate of exogenously ad-
ministered AHF the patient was given 
3782 units of glycine-precipitated AHF 2 
hr prior to operation on February 3, 1968. 
Splenic transplantation was completed in 
5 hr. The donor spleen was transplanted to 
the right extraperitoneal space of the re-
cipient by a previously described technique 
(5). The ischemic time from donor re-
moval to revascularization by the recipi-
ent was 60 min. After completion of the 
an2lstamoses it was necessary to readjust 
the position of the spleen many times be-
cause of kinking of either the anastamosed 
splrnic artery or vein. An additional 1800 
units of glycine-precipitated AHF were 
infused 2 hr after surgery was begun. The 
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FIGURE 1. The numbers at the top of the graph refer to units of Factor VIII given to the 
patient. A unit of factor VIII is that activity contained in the equivalent of 1 ml of fresh 
normal plasma. The dotted line represents an estimate of decay of exogenous factor VIII. 
patient tolerated the operation well. mood 
loss was estimated to be 50 ml. 
The recipient was followed b? routine 
laboratory studies plus daily factor VIII 
assays (Fig. 1). :\1edications were limited 
to i.v. fluids, antibiotics, ALG, azathio-
prine, Rnd Prednisone (McKesson Labora-
tories, Bridgeport, Connecticut). ~ 0 
further factor VIII was administered. 
Ambulation was begun on the 4th postop-
NatiYe day. In the evening of February 7, 
1968, the patient began to complain of 
exquisite pain oyer the right iliRc fossa ill 
the area of the incision. Because we were 
concerned with possible bleeding, the pa-
tient was given 1800 units of AHF cryo-
precipitate. Symptoms persisted, and the 
patient was taken to the operating room 
for exploration. At surgery approximately 
2 liters of fresh bloor! were found in tl](' 
iliac fossa along with several large clots. 
The tram;planted spleen was markedly 
swollell with three lacerations. Postopera-
tively the patient was kept continuously 
corrected with glycine-precipitated AHF 
or AHF cryoprecipitflte i.v. every 12 hr 
for 14 days. Factor VIII levels were main-
tained between 25-60%. No additioml 
problems were encountered, and he WRS 
discharged on February 27, 1968, with com-
plete healing of the incision. Since that 
time he had had four :ldditional hospital 
admissions for treatment of hemarthroses 
of his shoulder. 
Spleen scans with technetium sulfide 
done on February 4, HH18 (1 day postop-
l'rative) and on February 7, 1968 (2 hr 
prior to second laparotomy) showed good 
uptake over the patient's own spleen and 
the donor spleen. 
Pathological examination of the rup-
tllred donor spleen revealed prominent 
lymphoid nodules containing increased 
numbers of lymphocytes, histiocytes, and 
retirulum cells. 
COMMENTS 
.\8 showll in Figure 1, our patient main-
wined levels of at least 20% factor VIII 
for 4 clays, long after the effects of intra-
operative tl1f'rapy should have been dissi-
pated. It is impossible to say whether the 
factor VIII was newly synthesized or 
slowly released from storage in the dOllar 
spleen; however, if this level could have 
been maintained it would have trans-
formed the patient into a very mild hemo-
philiac. 
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T11r reasons for the rupture of the donor 
spken and suhsequent termination of this 
in vestiga tion remain unclear. Mechanical 
factors from the abnormal position of the 
organ, s\yelling or increased friability be-
cause of rejection, or trauma from too 
early amhulation of the patient could each 
have played a part. 
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